MedPath

Evolution of Pulsed Oxygen Saturation During Interval Training Compared to Continuous Training in COPD Patients

Recruiting
Conditions
COPD
Exercise
Desaturation of Blood
Pulmonary Rehabilitation
Registration Number
NCT05825638
Lead Sponsor
Groupe Hospitalier du Havre
Brief Summary

A problem often observed during exercise training is oxygen desaturation exclusively during exercise in some patients. In the case of exercise-induced desaturation, it may be suggested to train these patients in interval training to limit exercise-induced desaturation. Interval training consists of alternating active phases of short duration (often 30 seconds to 1 minute) followed by a short active or passive recovery phase of equivalent duration to the previous phase. Investigators therefore hypothesise that interval training on a cycloergometer or treadmill can limit exercise-induced desaturation in COPD patients.

The aim of the study is to observe the evolution of pulsed oxygen saturation between a continuous training session and a interval training session.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
12
Inclusion Criteria
  • a diagnosis of COPD
  • participating in a pulmonary rehabilitation programme
  • with an exercise-induced desaturation less than 90%
  • no oxygen supplementation
Exclusion Criteria
  • Under 18 years of age
  • Pregnant woman
  • Person not affiliated to a health insurance regime or not benefiting from a social security regime
  • Patient under curatorship, guardianship or safeguard of justice
  • Patient speaking a language other than French
  • Patient with severe hypoxaemia (SpO2 ≤ 80%) during exercise
  • Patient having had a moderate or severe exacerbation (hospitalisation for respiratory reasons) in the previous 4 weeks
  • Patients with orthopaedic, rheumatic, vascular or neurological pathology limiting their ability to make an effort
  • Breastfeeding women

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in oxygen pulsed saturationOne week

Difference in minimum saturation during both exercise, the measurement will be performed with a pulse oximeter (Spirodoc, MIR)

Secondary Outcome Measures
NameTimeMethod
Difference in oxygen pulsed saturationOne week

Difference in mean pulsed oxygen saturation and the time spent with a pulsed oxygen saturation below 90% during the two training sessions. The measurement will be performed with a pulse oximeter (Spirodoc, MIR)

Difference in respiratory rateOne week

Difference in respiratory rate will be measured breath-by-breath using a portable spirometer (Spirodoc, MIR)

Difference in tidal volumeOne week

Difference in tidal volume will be measured breath-by-breath using a portable spirometer (Spirodoc, MIR)

Difference in peripheral muscle oxygenationOne week

Muscle oxygenation (arbitrary unit) will be evaluated using Near-infrared spectroscopy technology. the measurement will be performed with a Near Infrared spectroscopy (Portamon, Artinis Medical Systems)

Difference in inspiratory capacityOne week

Difference in inspiratory capacity will be measured using a portable spirometer (Spirodoc, MIR)

Difference in muscle discomfortOne week

Muscle discomfort peak during exercise using the modified Borg scale 0-10, 0 no dyspnea, 10 maximal dyspnea

Difference in DyspneaOne week

Dyspnea peak during exercise using the modified Borg scale 0-10, 0 no dyspnea, 10 maximal dyspnea

Trial Locations

Locations (1)

Groupe Hospitalier du Havre

🇫🇷

Le Havre, Normandie, France

Groupe Hospitalier du Havre
🇫🇷Le Havre, Normandie, France
Guillaume Prieur
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.